This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Arthur J. Gallagher Set to Report Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Better performances in both segments are likely to aid AJG's fourth-quarter results.
Can RenaissanceRe Beat Q4 Earnings Estimates on Rising Premiums?
by Zacks Equity Research
RNR's fourth-quarter results are expected to benefit from increased demand for reinsurance and a favorable rate environment.
What's in the Cards for Chubb Limited This Earnings Season?
by Zacks Equity Research
CB's fourth-quarter results are likely to reflect solid premium retention, strong operating cash flow, new business and exposure increases across all lines.
Curious about RenaissanceRe (RNR) Q4 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for RenaissanceRe (RNR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.
What's in the Cards for W.R. Berkley This Earnings Season?
by Zacks Equity Research
WRB's fourth-quarter results are likely to reflect higher premiums at both the segments, partially offset by higher expenses.
Earnings Preview: Axis Capital (AXS) Q4 Earnings Expected to Decline
by Zacks Equity Research
Axis Capital (AXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RenaissanceRe (RNR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
RenaissanceRe (RNR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Travelers to Report Q4 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Better performances across all three segments are likely to aid TRV's fourth-quarter results.
Why RenaissanceRe (RNR) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why You Should Hold RenaissanceRe Stock in Your Portfolio
by Zacks Equity Research
RNR is expected to benefit from rising premiums, business expansions and strategic divestitures.
Why RenaissanceRe (RNR) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Will RenaissanceRe (RNR) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
RenaissanceRe (RNR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Buy, Sell or Hold RenaissanceRe Stock at a 1.34X P/B?
by Zacks Equity Research
Rising premiums, business expansions and strategic acquisitions should aid RNR's future growth.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Is RenaissanceRe (RNR) Up 8% Since Last Earnings Report?
by Zacks Equity Research
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why RenaissanceRe (RNR) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why RenaissanceRe (RNR) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AXIS Capital Rallies 65% YTD: Time to Buy the Stock for Solid Returns?
by Tanuka De
AXS continues to build on specialty insurance, reinsurance as well as the accident and health portfolio.
Here's Why RenaissanceRe (RNR) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why RenaissanceRe (RNR) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
RenaissanceRe's Q3 Earnings Beat Despite Rising Claims Costs
by Zacks Equity Research
RNR's Q3 results witness strong premium growth and higher yields from fixed maturity portfolio. However, higher claims costs contribute to increased overall expenses.
Here's What Key Metrics Tell Us About RenaissanceRe (RNR) Q3 Earnings
by Zacks Equity Research
Although the revenue and EPS for RenaissanceRe (RNR) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.